Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatinib & Trastuzumab Emtansine for Previously Treated HER2+ mBC"
By
Insights from 2023 SABCS
FEATURING
Sara A. Hurvitz
By
Insights from 2023 SABCS
FEATURING
Sara A. Hurvitz
337 views
December 12, 2023
Login to view comments.
Click here to Login
Videos